Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BITUPRO PROTIEN is a commercial nutritional supplement manufactured by Amvia Biotech (AMVIO). It is formulated as a protein powder primarily containing soya protein isolate, supplemented with a variety of vitamins and minerals including Vitamin A, D3, C, B-complex vitamins (B1, B2, B6, B12, Niacinamide, Folic Acid), and minerals such as Calcium, Iron (as Ferrous Gluconate), Zinc, and Copper. The product is marketed as a balanced nutritional supplement to support protein intake and overall health, often recommended for patients with increased nutritional demands such as during pregnancy or recovery from illness. Although sometimes listed alongside pharmaceutical generics in company portfolios, it is classified as a nutraceutical or dietary supplement rather than a small-molecule drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BITUPRO PROTIEN.